Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
579.00    0.00 (0.00%)
Bid:
579.00
Ask:
582.00
Spread: 3.00 (0.518%)
Market Cap: £841.81m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Director/PDMR Shareholding

21 Dec 2023 16:39

RNS Number : 6790X
SAGA PLC
21 December 2023

21 December 2023

SAGA PLC (THE COMPANY) - DIRECTOR/PDMR SHAREHOLDING

Pursuant to the notification obligations under Article 19 of the Market Abuse Regulation, the Company hereby notifies the following changes in the interests of directors and persons discharging managerial responsibility (PDMRs) in Ordinary Shares of 15 pence each in the Company (Shares).

Saga Transformation Plan

The Company's Saga Transformation Plan (the STP) was approved by the Company's shareholders at the 2022 Annual General Meeting (the 2022 AGM). The Company hereby announces the grant of awards to Executive Directors under the STP.

Participation Rights under the STP entitle the participant to receive, subject to the rules of the STP, a proportion (the Participant Proportion) of the Company's Total Shareholder Return above the qualifying hurdle of £6.00.

This value will be delivered through the grant of nil-cost options over Shares after a 5-year performance period.

More details of how the STP operates can be found in the Notice of 2022 AGM which can be found on our website at www.corporate.saga.co.uk/investors/agm.

Details of the award for the Chief Executive Officer and Chief Financial Officer are outlined below.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. Michael Hazell

2. Mark Watkins

2

Reason for the notification

a)

Position/status

1. Director, Group Chief Executive Officer

2. Director, Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Saga plc

b)

LEI

2138004WWUJN94K2LH95

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 15 pence

GB00BMX64W89

b)

Nature of the transaction

1. Grant of a conditional right, subject to the rules of the STP, to receive the value by which the Company's Total Shareholder Return exceeds the qualifying hurdle of £6.00, multiplied by 12.5% to form the STP Pool. This is then multiplied by a Participation Proportion of 12% (the CEO Award Value). The CEO Award Value will be delivered following the assessment of the Company's total shareholder return after the 5-year performance period by the grant of a nil-cost option over Shares.

2. Grant of a conditional right, subject to the rules of the STP, to receive the value by which the Company's Total Shareholder Return exceeds the qualifying hurdle of £6.00, multiplied by 12.5% to form the STP Pool. This is then multiplied by a Participation Proportion of 8% (the CFO Award Value). The CFO Award Value will be delivered following the assessment of the Company's total shareholder return after the 5 year performance period by the grant of a nil-cost option over Shares.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. £Nil

2. £Nil

1. Nil

2. Nil

d)

Aggregated information

- Aggregated volume

- Price

n/a

e)

Date of the transaction

21 December 2023

f)

Place of the transaction

London

Enquiries

Saga plc

3 Pancras Square

London N1C 4AG

Vicki Haynes

Company Secretary

07803 602139

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFVRFTLLFIV
Date   Source Headline
26th May 20269:00 amRNSNotice of AGM/ Annual Report and Accounts
12th May 20264:23 pmRNSTotal Voting Rights
8th May 202611:45 amRNSIssue of Equity
23rd Apr 20264:42 pmRNSDirector/PDMR Shareholding
23rd Apr 20264:40 pmRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSPreliminary results for the year ended 31 Jan 2026
23rd Mar 20261:59 pmRNSCommittee Changes
3rd Mar 20267:00 amRNSAppointment of Joint Corporate Brokers
27th Feb 20264:00 pmRNSDirectorate change
29th Jan 20267:00 amRNSTrading Update
16th Dec 20257:00 amRNSSaga and Ageas Insurance partnership goes live
30th Sep 20252:40 pmRNSHolding(s) in Company
29th Sep 202510:15 amRNSDirector/PDMR Shareholding
24th Sep 20257:00 amRNS2025-26 interim results statement
15th Jul 20259:00 amRNSTotal Voting Rights
14th Jul 20257:00 amRNSSaga Money launches partnership with NatWest
9th Jul 202512:00 pmRNSCommittee changes
9th Jul 202511:49 amRNSIssue of Equity
1st Jul 20253:57 pmRNSHolding(s) in Company
1st Jul 20252:09 pmRNSAcromas Insurance Company Limited Completion
26th Jun 20251:49 pmRNSDirector/PDMR Shareholding
24th Jun 20251:13 pmRNSResult of AGM
24th Jun 20259:02 amRNSDirector Declaration
24th Jun 20257:00 amRNSAGM Trading Update
29th May 20252:38 pmRNSDirector/PDMR Shareholding
20th May 20259:00 amRNSNotice of AGM
11th Apr 202511:00 amRNSHolding(s) in Company
10th Apr 20257:30 amRNSDirector/PDMR Shareholding
9th Apr 20253:54 pmRNSDirector/PDMR Shareholding
9th Apr 20257:01 amRNSDirectorate Change
9th Apr 20257:00 amRNSFinal Results
13th Mar 20258:00 amRNSDirector Declaration
28th Feb 20257:00 amRNSRepayment of corporate debt and new draw down
12th Feb 20258:00 amRNSDirector Declaration
30th Jan 20257:01 amRNSTrading Update
30th Jan 20257:00 amRNSSaga successfully refinances corporate debt
16th Dec 20247:00 amRNSSaga and Ageas agree new Insurance partnership
10th Dec 20243:57 pmRNSDirector Declaration
24th Oct 20247:35 amRNSCorrection - Director Declaration
24th Oct 20247:35 amRNSDirector Declaration
11th Oct 20247:00 amRNSInterim results for the six months ended 31 July
11th Oct 20247:00 amRNSSaga and Ageas in exclusive negotiations
2nd Oct 20247:00 amRNSResponse to Media Coverage
1st Oct 20244:23 pmRNSDelay to publication of H1 2024 results
1st Oct 20248:59 amRNSDirector Declaration
9th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 20243:00 pmRNSCorrection - Result of AGM
25th Jun 20242:19 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Trading Update
12th Jun 20244:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.